Publisher
Springer Science and Business Media LLC
Subject
Law,Clinical Biochemistry,Spectroscopy,Sociology and Political Science,Social Sciences (miscellaneous),Clinical Psychology,Biochemistry
Reference42 articles.
1. Global Leading Categories of Diseases/Disorders (YLDs).
https://www.nimh.nih.gov/Health/statistics/global/global-leading-categories-of-diseases-disorders-ylds.shtml
. Accessed 25 Jan 2019
2. Eli Lilly, Company, ZYPREXA (olanzapine) tablet for oral use: Prescribing Information (2018)
https://www.fda.gov/media/75933/download.
Accessed 25 Jan 2020
3. Carlson CD, Cavazzoni PA, Berg PH, Wei H, Kane JM (2003) An integrated analysis of acute treatment emergent extrapyramidal syndrome in patients with schizophrenia during olanzapine clinical trials: comparisons with placebo, haloperidol, risperidone or clozapine. J Clin Psychiatry 64:898–906.
https://doi.org/10.4088/jcp.v64n0807
4. Carrillo JA, Herráiz AG, Ramos SI, Gervasini G, Vizcaíno S, Benítez J (2003) Role of the smoking induced cytochrome P450 (CYP)1A2 and polymorphic CYP2D6 in steady-state concentration of olanzapine. J Clin Psychopharmacol 23:119–127.
https://doi.org/10.1097/00004714-200304000-00003
5. Gex-fabry M, Balant-gorgia AE, Balant LP (2003) Therapeutic drug monitoring of olanzapine: the combined effect of age, gender, smoking, and comedication. Ther Drug Monit 25:46–53.
https://doi.org/10.1097/00007691-200302000-00007
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献